RNA epigenetic modifications have uncovered as not only an intermediary structure between DNA and protein or an effector ...

RNA therapeutics have existed since the late 90s but have only ... Another promising strategy for delivering RNA-based drugs is through chemical modification. These modifications can include changes ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...

Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...

AI and machine learning in RNA therapeutics As we neared the end ... There are more than 100 different types of RNA modifications, but these need to be precisely placed to maximise their impact.

EnPlusOne Biosciences, Inc., a biotechnology company harnessing the power of enzymes to deliver better RNA at scale, today ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with stability and specificity. Alnylam, Ionis, and Sarepta lead the RNA ...

RNA therapeutics market is expanding, driven by advancements in gene therapy, personalized medicine, and RNA-based drug delivery, along with rising research in mRNA vaccines, antisense ...

Oligonucleotide Synthesis Market Size & Growth Analysis: According to a new report by SNS Insider, the global Oligonucleotide Synthesis Market was valued at USD 3.72 billion in 2023 and is projected ...

"With RNA increasingly seen as both a drug and a druggable target," the scientists wrote, "this opens the potential for RNA-based therapeutics ... and protein modifications are critical for ...

Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...